HIGH CARDIOVASCULAR RISK

Clinical trials for HIGH CARDIOVASCULAR RISK explained in plain language.

Never miss a new study

Get alerted when new HIGH CARDIOVASCULAR RISK trials appear

Sign up with your email to follow new studies for HIGH CARDIOVASCULAR RISK, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Completed 1

Major heart study tests new shot to slash heart attack and stroke risk

Disease control Recruiting now

This study is testing whether adding a new investigational drug called zilebesiran to standard blood pressure medications can lower the risk of serious heart problems like heart attack, stroke, or heart failure. It will involve about 11,000 adults with high blood pressure that is…

Matched conditions: HIGH CARDIOVASCULAR RISK

Phase: PHASE3 • Sponsor: Alnylam Pharmaceuticals • Aim: Disease control

Last updated Apr 01, 2026 14:42 UTC

HIGH CARDIOVASCULAR RISK

Get alerted when new HIGH CARDIOVASCULAR RISK trials appear

Major heart study tests new shot to slash heart attack and stroke risk